Work

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(13)60250-0

Authors: Cem Gabay, Paul Emery, Ronald van Vollenhoven, Ara Dikranian, Rieke Alten, Karel Pavelka, Micki Klearman, David Musselman, Sunil Agarwal, Jennifer Green, Arthur Kavanaugh

Institutions: University Hospital of Geneva, University of Leeds, Karolinska Institutet, Genentech, Roche (United Kingdom), University of California San Diego

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Roche, National Institute for Health and Care Research, Versus Arthritis

Awards: NIHR Senior Investigator Award, G8903934815

OpenAlex ID: W2102207725

FWCI: 48.32

Cites: 40

Cited by: 679

Related to: 10